539111 (3)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE received clarifications from Nexus Surgical, Sheshadri Industries, and Takyon Networks regarding significant price/volume movements. … | |||||||||||||||
BSE received clarifications from Nexus Surgical, Sheshadri Industries, and Takyon Networks regarding significant price/volume movements. Replies are still awaited from four other companies including Adhata Global and ZR2 Bioenergy.
| |||||||||||||||
BSE's Surveillance department sought clarifications from 15 companies regarding significant price/volume movements. Replies received from 9 … | |||||||||||||||
BSE's Surveillance department sought clarifications from 15 companies regarding significant price/volume movements. Replies received from 9 companies; 6 companies' responses are still awaited.
| |||||||||||||||
BSE revises price bands for 26 equity scrips effective May 11, 2026, with bands ranging from 1% to 20%, as part of routine surveillance … | |||||||||||||||
BSE revises price bands for 26 equity scrips effective May 11, 2026, with bands ranging from 1% to 20%, as part of routine surveillance measures.
| |||||||||||||||